Wedi CO, Kirtley S, Hopewell S, Corrigan R, Kennedy SH, Hemelaar J. Perinatal outcomes associated with maternal HIV infection: a systematic review and meta-analysis. Lancet HIV. 2016;3(1):e33-48.
CDC. HIV and Pregnant Women, Infants, and Children [Available from: https://www.cdc.gov/hiv/group/gender/pregnantwomen/index.html.
Centers for Disease Control and Prevention. Viral hepatitis surveillance — United States. 2018. https://www.cdc.gov/hepatitis/statistics/SurveillanceRpts.htm. Accessed 13 June 2022
Patrick SW, Bauer AM, Warren MD, Jones TF, Wester C. Hepatitis C virus infection among women giving birth - Tennessee and United States, 2009–2014. MMWR Morb Mortal Wkly Rep. 2017;66(18):470–3.
Bosh KA, Coyle JR, Hansen V, Kim EM, Speers S, Comer M, et al. HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities. Epidemiol Infect. 2018;146(7):920–30.
Morse A, BarrittASt, Jhaveri R. Individual state hepatitis C data supports expanding screening beyond baby boomers to all adults. Gastroenterology. 2018;154(6):1850-1 e2.
Tasillo A, Eftekhari Yazdi G, Nolen S, Schillie S, Vellozzi C, Epstein R, et al. Short-term effects and long-term cost-effectiveness of universal hepatitis C testing in prenatal care. Obstet Gynecol. 2019;133(2):289–300.
Schillie S, Wester C, Osborne M, Wesolowski L, Ryerson AB. CDC recommendations for hepatitis C screening among adults - United States, 2020. MMWR Recomm Rep. 2020;69(2):1–17.
Patrick SW, Dupont WD, McNeer E, McPheeters M, Cooper WO, Aronoff DM, Osmundson S, Stein BD. Association of individual and community factors with hepatitis C infections among pregnant people and newborns. JAMA Health Forum 2021;2(10):e213470. https://doi.org/10.1001/jamahealthforum.2021.3470. Erratum in: JAMA Health Forum 2021;2(12):e214347
Jhaveri R. Elimination means everyone: targeting hepatitis C in infants and pregnant patients. Clin Infect Dis. 2022. https://doi.org/10.1093/cid/ciac330
Chen Q, Ayer T, Bethea E, Kanwal F, Wang X, Roberts M, et al. Changes in hepatitis C burden and treatment trends in Europe during the era of direct-acting antivirals: a modelling study. BMJ Open. 2019;9(6):e026726.
Espinosa C, Jhaveri R, BarrittASt. Unique challenges of hepatitis C in infants, children, and adolescents. Clin Ther. 2018;40(8):1299-307.
Jhaveri R, Yee LM, Antala S, Murphy M, Grobman WA, Shah SK. Responsible inclusion of pregnant individuals in eradicating HCV. Hepatology. 2021;74(3):1645–51.
Baroncelli S, Pirillo MF, Amici R, Tamburrini E, Genovese O, Ravizza M, et al. HCV-HIV coinfected pregnant women: data from a multicentre study in Italy. Infection. 2016;44(2):235–42.
Benhammou V, Tubiana R, Matheron S, Sellier P, Mandelbrot L, Chenadec JL, et al. HBV or HCV coinfection in HIV-1-infected pregnant women in France: prevalence and pregnancy outcomes. J Acquir Immune Defic Syndr. 2018;77(5):439–50.
Domínguez-Rodríguez S, Prieto L, Fernández McPhee C, Illán-Ramos M, Beceiro J, Escosa L, Muñoz E, Olabarrieta I, Regidor FJ, Roa MÁ, Viñuela Beneítez MDC, Guillén S, Navarro-Gómez ML, Ramos Amador JT; Madrid Cohort of HIV-infected mother-infant pairs. Perinatal HCV Transmission Rate in HIV/HCV Coinfected women with access to ART in Madrid, Spain. PLoS One. 2020;15(4):e0230109. https://doi.org/10.1371/journal.pone.0230109.
Benova L, Mohamoud YA, Calvert C, Abu-Raddad LJ. Vertical transmission of hepatitis C virus: systematic review and meta-analysis. Clin Infect Dis. 2014;59(6):765–73.
Epstein RL, Sabharwal V, Wachman EM, Saia KA, Vellozzi C, Hariri S, et al. Perinatal transmission of hepatitis C virus: defining the cascade of care. J Pediatr. 2018;203(34–40):e1.
Krans EE, Zickmund SL, Rustgi VK, Park SY, Dunn SL, Schwarz EB. Screening and evaluation of hepatitis C virus infection in pregnant women on opioid maintenance therapy: a retrospective cohort study. Subst Abus. 2016;37(1):88–95.
Jarlenski M, Chen Q, Ahrens KA, Allen L, Austin AE, Chappell C, Donohue JM, Hammerslag L, Lanier P, McDuffie MJ, Talbert J, Tang L, Krans EE; Medicaid outcomes distributed research network (MODRN). Postpartum follow-up care for pregnant persons with opioid use disorder and hepatitis C virus infection. Obstet Gynecol. 2022;139(5):916–918. https://doi.org/10.1097/AOG.0000000000004760.
Ko JY, Haight SC, Schillie SF, Bohm MK, Dietz PM. National trends in hepatitis C infection by opioid use disorder status among pregnant women at delivery hospitalization - United States, 2000-2015. MMWR Morb Mortal Wkly Rep. 2019;68(39):833–838. https://doi.org/10.15585/mmwr.mm6839a1.
Ly KN, Jiles RB, Teshale EH, Foster MA, Pesano RL, Holmberg SD. Hepatitis C virus infection among reproductive-aged women and children in the United States, 2006 to 2014. Ann Intern Med. 2017;166(11):775–82.
Ghazaryan L, Smith L, Parker M, Flanigan C, Pulver W, Sullivan T, et al. Hepatitis C seroprevalence among HIV-infected childbearing women in New York State in 2006. Matern Child Health J. 2016;20(3):550–5.
Gervais A, Bacq Y, Bernuau J, Martinot M, Auperin A, Boyer N, et al. Decrease in serum ALT and increase in serum HCV RNA during pregnancy in women with chronic hepatitis C. J Hepatol. 2000;32(2):293–9.
Chappell CA, Jonas MM. Hepatitis C virus in pregnancy: are we ready for test and treat? J Infect Dis. 2020;222(Suppl 9):S789–93.
Coss SL, Torres-Cornejo A, Prasad MR, Moore-Clingenpeel M, Grakoui A, Lauer GM, et al. CD4+ T cell restoration and control of hepatitis C virus replication after childbirth. J Clin Invest. 2020;130(2):748–53.
Barritt ASt, Jhaveri R. Treatment of hepatitis C during pregnancy-weighing the risks and benefits in contrast to HIV. Curr HIV/AIDS Rep. 2018;15(2):155–61.
Piffer S, Mazza A, Dell’Anna L. Serological screening for hepatitis C during pregnancy: Seroprevalence and maternal and neonatal outcomes in 45,000 pregnant women. Eur J Obstet Gynecol Reprod Biol. 2020;254:195–9.
Wijarnpreecha K, Thongprayoon C, Sanguankeo A, Upala S, Ungprasert P, Cheungpasitporn W. Hepatitis C infection and intrahepatic cholestasis of pregnancy: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2017;41(1):39–45.
Panel AIHG. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus. Hepatology. 2015;62(3):932–54.
Prasad MR, Honegger JR. Hepatitis C virus in pregnancy. Am J Perinatol. 2013;30(2):149–59.
Huang QT, Hang LL, Zhong M, Gao YF, Luo ML, Yu YH. Maternal HCV infection is associated with intrauterine fetal growth disturbance: a meta-analysis of observational studies. Medicine (Baltimore). 2016;95(35):e4777.
Zanetti AR, Tanzi E, Paccagnini S, Principi N, Pizzocolo G, Caccamo ML, et al. Mother-to-infant transmission of hepatitis C virus. Lombardy Study Group on Vertical HCV Transmission. Lancet. 1995;345(8945):289–91.
Ngo-Giang-Huong N, Jourdain G, Sirirungsi W, Decker L, Khamduang W, Le Coeur S, et al. Human immunodeficiency virus-hepatitis C virus co-infection in pregnant women and perinatal transmission to infants in Thailand. Int J Infect Dis. 2010;14(7):e602–7.
Conte D, Fraquelli M, Prati D, Colucci A, Minola E. Prevalence and clinical course of chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology. 2000;31(3):751–5.
AASLD-IDSA. HCV guidance: recommendations for testing, managing, and treating hepatitis C: HCV in children [Available from: https://www.hcvguidelines.org/unique-populations/children
Protopapas S, Murrison LB, Wexelblatt SL, Blackard JT, Hall ES. Addressing the disease burden of vertically acquired hepatitis C virus infection among opioid-exposed infants. Open Forum Infect Dis. 2019;6(12):ofz448.
Rogers ME, Balistreri WF. Cascade of care for children and adolescents with chronic hepatitis C. World J Gastroenterol. 2021;27(12):1117–31.
Lopata SM, McNeer E, Dudley JA, Wester C, Cooper WO, Carlucci JG, Espinosa CM, Dupont W, Patrick SW. Hepatitis C testing among perinatally exposed infants. Pediatrics. 2020;145(3):e20192482. https://doi.org/10.1542/peds.2019-2482
Kuncio DE, Newbern EC, Johnson CC, Viner KM. Failure to test and identify perinatally infected children born to hepatitis C virus-infected women. Clin Infect Dis. 2016;62(8):980–5.
Chappell CA, Hillier SL, Crowe D, Meyn LA, Bogen DL, Krans EE. Hepatitis C virus screening among children exposed during pregnancy. Pediatrics. 2018;141(6):e20173273. https://doi.org/10.1542/peds.2017-3273.
Bell R, Wolfe I, Cox D, Thakarar K, Lucas L, Craig A. Hepatitis C screening in mothers and infants exposed to opioids. Hosp Pediatr. 2019;9(8):639–42.
European Paediatric Hepatitis CVN. Three broad modalities in the natural history of vertically acquired hepatitis C virus infection. Clin Infect Dis. 2005;41(1):45–51.
Bortolotti F, Verucchi G, Camma C, Cabibbo G, Zancan L, Indolfi G, et al. Long-term course of chronic hepatitis C in children: from viral clearance to end-stage liver disease. Gastroenterology. 2008;134(7):1900–7.
Rodrigue JR, Balistreri W, Haber B, Jonas MM, Mohan P, Molleston JP, et al. Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes. J Pediatr Gastroenterol Nutr. 2009;48(3):341–7.
Squires JE, Balistreri WF. Hepatitis C virus infection in children and adolescents. Hepatol Commun. 2017;1(2):87–98.
Younossi Z, Park H, Henry L, Adeyemi A, Stepanova M. Extrahepatic manifestations of hepatitis C: a meta-analysis of prevalence, quality of life, and economic burden. Gastroenterology. 2016;150(7):1599–608.
Gowda C, Smith S, Crim L, Moyer K, Sanchez PJ, Honegger JR. Nucleic acid testing for diagnosis of perinatally acquired hepatitis C virus infection in early infancy. Clin Infect Dis. 2021;73(9):e3340–6.
Routine hepatitis C virus screening in pregnant individuals [Available from: https://www.acog.org/clinical/clinical-guidance/practice-advisory/articles/2021/05/routine-hepatitis-c-virus-screening-in-pregnant-individuals
Kaufman HW, Osinubi A, Meyer WA 3rd, Khan M, Huang X, Panagiotakopoulos L, et al. Hepatitis C virus testing during pregnancy after universal screening recommendations. Obstet Gynecol. 2022;140(1):99–101.
Adolescents PoAGfAa. Guidelines for the use of antiretroviral agents in adults and adolescents with HIV. Department of Health and Human Services [Available from: https://clinicalinfo.hiv.gov/en/guidelines/adult-and-adolescent-arv.
Radwan D, Cachay E, Falade-Nwulia O, Moore RD, Westergaard R, Mathews WC, et al. HCV screening and treatment uptake among patients in HIV care during 2014–2015. J Acquir Immune Defic Syndr. 2019;80(5):559–67.
Panel on treatment of HIV during pregnancy and prevention of perinatal transmission. Recommendations for the use of antiretroviral drugs during pregnancy and interventions to reduce perinatal HIV transmission in the United States [Available from: https://clinicalinfo.hiv.gov/en/guidelines/perinatal.
Boucoiran I, Albert AYK, Tulloch K, Wagner EC, Pick N, van Schalkwyk J, et al. Human immunodeficiency virus viral load rebound near delivery in previously suppressed, combination antiretroviral therapy-treated pregnant women. Obstet Gynecol. 2017;130(3):497–501.
Sibiude J, Warszawski J, Tubiana R, Le Chenadec J, Meier F, Faye A, et al. Liver enzyme elevation in pregnant women receiving antiretroviral therapy in the ANRS-French perinatal cohort. J Acquir Immune Defic Syndr. 2019;81(1):83–94.
Chou R, Dana T, Fu R, Zakher B, Wagner J, Ramirez S, Grusing S, Jou JH. Screening for hepatitis C virus infection in adolescents and adults: a systematic review update for the U.S. preventive services task force [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); Report No.: 19-05256-EF-1. 2020
Mast EE, Hwang LY, Seto DS, Nolte FS, Nainan OV, Wurtzel H, et al. Risk factors for perinatal transmission of hepatitis C virus (HCV) and the natural history of HCV infection acquired in infancy. J Infect Dis. 2005;192(11):1880–9.
Society for Maternal-Fetal Medicine .Electronic address pso, Hughes BL, Page CM, Kuller JA. Hepatitis C in pregnancy: screening, treatment, and management. Am J Obstet Gynecol. 2017;217(5):B2-B12.
Gibb DM, Goodall RL, Dunn DT, Healy M, Neave P, Cafferkey M, et al. Mother-to-child transmission of hepatitis C virus: evidence for preventable peripartum transmission. Lancet. 2000;356(9233):904–7.
留言 (0)